Pfizer Azione

Pfizer Debiti verso fornitori

Il Debiti Commerciali di Pfizer (PFIZER.NS) al 21 ago 2026 è 1,52 miliardi INR. L'anno precedente, Debiti Commerciali era 1,66 miliardi INR — una variazione del -8,80% (inferiore).

Debiti verso fornitori

1,52 miliardiINR

YoY

-8,80%

Ultimo aggiornamento:

Debiti Commerciali di Pfizer ammonta a 2026 1,52 miliardi INR. Debiti Commerciali di Pfizer ammontava a 2025 1,66 miliardi INR. Diminuisce del -8,80% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Pfizer Analisi delle Azioni

Cosa fa Pfizer? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Pfizer azioni

Debiti Commerciali di Pfizer è 1,52 miliardi INR nel 2026.

Il Debiti Commerciali di Pfizer è passato da 1,66 miliardi INR a 1,52 miliardi INR, con una variazione del -8,80 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Pfizer di Debiti Commerciali dal 2006, con valori annuali, grafici e analisi dettagliate.

I debiti commerciali rappresentano il denaro dovuto ai fornitori per beni e servizi ricevuti. È un componente fondamentale della gestione del capitale di esercizio.

Il INR di Debiti Commerciali è un fattore chiave per gli investitori. I cambiamenti in questa metrica possono segnalare il miglioramento o il deterioramento dei fondamentali, impattando direttamente il prezzo delle azioni. Su Eulerpool puoi tracciare il Pfizer di Debiti Commerciali storicamente e in tempo reale.

Access this data via the Eulerpool API

Bilancio — Pfizer

Tutte le Metriche Finanziarie — Pfizer